1. Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie
- Author
-
Ângela Correia, Juan José Badiola, Rosa Bolea, Inga Zerr, Peter Lange, Franc Llorens, Ingolf Lachmann, Matthias Schmitz, Tomás Barrio, Katrin Thüne, Anna Villar-Piqué, Centro de Encefalopatías y Enfermedades Transmisibles Emergentes, and University of Zaragoza - Universidad de Zaragoza [Zaragoza]
- Subjects
pathology [Scrapie] ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Neurology ,Prions ,animal diseases ,[SDV]Life Sciences [q-bio] ,Tau protein ,Neuroscience (miscellaneous) ,Scrapie ,Disease ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Cerebrospinal fluid ,ddc:570 ,medicine ,Disease biomarker ,Animals ,Prion protein ,14-3-3 protein ,ComputingMilieux_MISCELLANEOUS ,Sheep ,biology ,business.industry ,nervous system diseases ,3. Good health ,cerebrospinal fluid [Prions] ,030104 developmental biology ,cerebrospinal fluid [Biomarkers] ,biology.protein ,Female ,business ,030217 neurology & neurosurgery ,Biomarkers ,cerebrospinal fluid [Scrapie] - Abstract
The analysis of the cerebrospinal fluid (CSF) biomarkers in patients with suspected prion diseases became a useful tool in diagnostic routine. Prion diseases can only be identified at clinical stages when the disease already spread throughout the brain and massive neuronal damage occurs. Consequently, the accuracy of CSF tests detecting non-symptomatic patients is unknown. Here, we aimed to investigate the usefulness of CSF-based diagnostic tests in pre-clinical and clinical naturally occurring scrapie. While decreased total prion protein (PrP) levels and positive PrP seeding activity were already detectable at pre-symptomatic stages, the surrogate markers of neuronal damage total tau (tau) and 14-3-3 proteins were exclusively increased at clinical stages. The present findings confirm that alterations in PrP levels and conformation are primary events in the pathology of prion diseases preceding neuronal damage. Our work also supports the potential use of these tests in the screening of pre-symptomatic scrapie and human prion disease cases.
- Published
- 2017